United States:
D. Mass. Patent Litigation Update, September 2023
03 November 2023
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
To print this article, all you need is to be registered or login on Mondaq.com.
This is part of a series of articles discussing recent
orders of interest issued in patent cases by the United States
District Court for the District of Massachusetts.
In ModernaTX, Inc. v. Pfizer
Inc., No. 1:22-cv-11378, Judge Stearns granted
Moderna's motion to compel Defendants to respond to
interrogatories and detail (i) their knowledge of the nature of
Moderna's work in the mRNA vaccine space and (ii) state the
date on which they first became aware of the patent.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
USPTO Embraces AI Tools In New Guidance
Crowell & Moring LLP
On April 11, 2024, the USPTO published its "Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States" in the Federal Register (the "Guidance"). As the title suggests...
Breaking Down The EPO's Revised Practice Guidelines
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The guidelines for examination in the European Patent Office instruct on the practice and procedure related to the examination of European patent applications...
USPTO Issues Guidance On Use Of AI-Based Tools
Greenberg Traurig, LLP
On April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies existing rules and policies...